Evidence map›Paper›PMID 29122627›Full record

ReviewNeuropharmacology2018

Glial function (and dysfunction) in the normal & ischemic brain.

Shino D Magaki, Christopher K Williams, Harry V Vinters

Open access · greenAbstract readReview
In one paragraph

Review in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Impairment of the Glial Phagolysosomal System Drives Prion-Like Propagation in aThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Neuropathologic Findings in Elderly HIV-Positive Individuals.Journal of neuropathology and experimental neurology · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shino D MagakiDepartment of Pathology, Loma Linda University Medical Center, Loma Linda, CA, USA; Department of Pathology & Laboratory Medicine (Neuropathology), David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1732, USA. Electronic address: smagaki@llu.edu.
Christopher K WilliamsDepartment of Pathology & Laboratory Medicine (Neuropathology), David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1732, USA.
Harry V VintersDepartment of Pathology & Laboratory Medicine (Neuropathology), David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1732, USA; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1732, USA. Electronic address: hvinters@mednet.ucla.edu.
University of California, Los Angeles · USLoma Linda University Medical Center · US

Funding

UCLA SPORE in Brain CancerP50CA211015 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI David A. Nathanson · 2017 to 2026
$25.2M
Cerebral Amyloid Angiopathy and Related Cerebral MicrovasculopathiesR13AG035492 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VINTERS, HARRY V. · 2009 to 2009
$20k
NCI NIH HHS P50 CA211015NIA NIH HHS R13 AG035492
6 · The paper itself

Abstract

Astrocytes are the most abundant cell type in the central nervous system (CNS). Once considered to be of fairly homogeneous phenotype throughout the brain and spinal cord, they are now understood to be heterogeneous in both structure and function. They are important in brain functions as diverse as ion and fluid balance in the interstitial space, contributing to integrity of the neurovascular unit (blood-brain barrier), neurotransmitter regulation, metabolism of energy substrates and possibly even axonal regeneration. After ischemic or hemorrhagic brain/spinal cord injury, formation of an astrocytic scar adjacent to the 'lesion' is a characteristic histopathologic feature, and this astrogliosis can be demonstrated by immunohistochemistry, usually using primary antibodies to glial fibrillary acidic protein (GFAP). Astrocytes interact with microglia and oligodendroglia in novel ways that will be discussed in this review. This article is part of the Special Issue entitled 'Cerebral Ischemia'.

Indexed as

AnimalsBlood-Brain BarrierBrain IschemiaGlial Fibrillary Acidic ProteinGliosisHumansNeurotransmitter AgentsGlial Fibrillary Acidic ProteinNeurotransmitter AgentsAstrocytesBrain injury - responsesIntracerebral hemorrhageIschemiaMicrogliaOligodendroglia

Identifiers

PMID29122627
PMCPMC6132239
OpenAlexW2767506707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.